Anticancer agent 127
Anticancer agent 127 (142D6) is an IAP inhibitor that covalently targets the BIR3 domains of XIAP, cIAP1, and cIAP2. Anticancer agent 127 targets the BIR3 domains of XIAP, cIAP1, and cIAP2 with IC50s of 12 nM, 14 nM, and 9 nM, respectively. Anticancer agent 127 has anticancer effects[1].
Product Specifications
CAS Number
2410953-19-2
UNSPSC
12352005
Target
IAP
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-127.html
Solubility
10 mM in DMSO
Smiles
O=C(N1[C@H](C(N[C@H]2C(C=CC=C3OS(=O)(F)=O)=C3CC2)=O)CCC1)[C@H](C4CCCCC4)NC([C@H](C)NC)=O
Molecular Formula
C26H37FN4O6S
Molecular Weight
552.66
References & Citations
[1]Udompholkul P, et al. Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist. J Med Chem. 2023 Jun 22;66 (12) :8159-8169.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR224353L3V 200 µL
Ppm1b (NM_011151) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
K1630503 1.0 µg DNA
PFDN2 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details